Tech & Pharma

University Of Melbourne Develops Therapy For Parkinson’s Disease

University Of Melbourne Develops Therapy For Parkinson’s Disease

The University of Melbourne and Procypra Therapeutics have agreed to develop therapy to treat Parkinson’s disease.

Australia And India To Collaborate On Clean Fuel Production

Australia And India To Collaborate On Clean Fuel Production

A six million dollar Australia-India partnership project will focus on improving processes involved in the production of dimethyl ether (DME), a clean-burning synthetic fuel.

Singapore-Korea Collaboration In Sustainable Chemicals

Singapore-Korea Collaboration In Sustainable Chemicals

Research institutes in Singapore and Korea will team up to promote joint research and collaboration in the field of sustainable chemicals.

Phase 1/2 Results For Takeda’s Norovirus Vaccine

Phase 1/2 Results For Takeda’s Norovirus Vaccine

Takeda has announced the results of a Phase 1/2 study of its norovirus vaccine candidate which was found to be well tolerated.

Hutchison MediPharma And Eli Lilly Collaborate On Cancer Therapy

Hutchison MediPharma And Eli Lilly Collaborate On Cancer Therapy

Hutchison MediPharma has entered into a collaboration with Eli Lilly to develop fruquintinib, a targeted oncology therapy against solid tumors.

Apollo Hospitals And Medtronic Bring Hemodialysis System To India

Apollo Hospitals And Medtronic Bring Hemodialysis System To India

Apollo Hospitals and Medtronic have announced a collaboration to bring an affordable and portable hemodialysis system to India.

ASLAN Pharmaceuticals Secures US$22m In Series B Financing

ASLAN Pharmaceuticals Secures US$22m In Series B Financing

ASLAN Pharmaceuticals has raised US$22 million after hosting a second round of financing with Cenova Ventures.

Otsuka Pharma Completes Acquisition Of Astex Pharma For US$886m

Otsuka Pharma Completes Acquisition Of Astex Pharma For US$886m

Otsuka Pharma has successfully completed its acquisition of Astex Pharmaceuticals, Inc. for US$8.50 per share.

Micell Technologies Brings MiStent SES To China

Micell Technologies Brings MiStent SES To China

Micell Technologies and Hefei Life Science will develop, market and distribute the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System in China.

PAREXEL Launches Platform For Clinical Trial Registration

PAREXEL Launches Platform For Clinical Trial Registration

PAREXEL has launched a service called China Trials Solution to provide clients with local market knowledge and resources.